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Abstract
Background: Evidence from pilot trials suggests that structured learning techniques may have positive effects on
the performance of cognitive tasks, movement sequences or skills in patients with Alzheimer’s disease. The purpose
of this trial is to evaluate whether the usual method of learning by trial and error or the method of errorless
learning demonstrate better effects on the performance of two selected daily living tasks six weeks after the
intervention in people with mild to moderate dementia.
Methods/Design: A seven-centre single-blind, active-controlled design with a 1:1 randomisation for two parallel
groups will include 175 persons diagnosed with Alzheimer’s disease or mixed type dementia (MMSE 14-24), living
at home, showing at least moderate need for assistance in instrumental activities of daily living; primary carer
available and informed consent of patient and primary carer. Patients of both study arms will receive 15 one-hour-
sessions at home by trained interventionists practising two daily living tasks individually selected. In one group the
trial and error technique and in the other group the errorless learning method will be applied. Primary outcome is
the task performance measured with the Task Performance Scale six weeks post treatment.
Discussion: The trial results will inform us to improve guidelines for instructing individuals with memory
impairments. A user-friendly practice guideline will allow an efficient implementation of structured relearning
techniques for a wide range of service providers in dementia care.
Trial registration: DRKS00003117
Background
Dementia is a neurodegenerative progressive disease
with high prevalence and incidence rates and enormous
costs for international societies [1-7]. Consequences of
dementia are an increasing deterioration of patients’
daily functioning and a high burden mainly borne by
the primary carers or nursing staff in nursing homes
and in the community [8-10]. Relearning of relevant
daily-living tasks in dementia has the potential to stabi-
lise the daily functioning of people with dementia and
to increase their independency. Alzheimer’s Disease
(AD) alters memory and learning to such a degree that
it heavily interferes with daily living. Normally, learning
occurs in an unstructured manner by trial and error,
which consists of guessing and the occurrence of errors
during acquisition. Errorless learning is a teaching tech-
nique using feed-forward instruction, in order to prevent
people from making mistakes during the learning pro-
cess. In AD patients, the amount of such errors may be
reduced by providing adapted cues prior to performing
the target task and limiting the patient’s guessing [11].
Evidence from small-scaled pilot trials suggests that
errorless learning techniques may have positive effects
on the performance of cognitive tasks, movement
sequences or skills in patients with AD [11-17]. A meta-
analysis found large effect sizes in favour of errorless
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learning (d = 0.87, p = 0.008) [18]. The Nijmegen
research group compared the effects of learning strate-
gies on activities of daily living in a pilot trial with 12
AD patients from nursing homes and day care centres.
Patients in the errorless learning group significantly
improved their performances with large effect size after
six sessions (h2p = 0.8, p < 0.01) and at delayed assess-
ment (h2p = 0.5, p = 0.01) [19]. These preliminary data
show that people with AD can relearn tasks they were
not able to perform before. However, the results need to
be replicated at a larger scale and within the patient’s
familiar environment.
Therefore, the purpose of our multi-centre REDALI-
DEM study is to evaluate whether the usual method of
learning by trial and error (TEL) or the method of error-
less learning (ELL) demonstrate better effects on the per-
formance of two selected daily living tasks six weeks after
the intervention in people with mild to moderate demen-
tia living at home. Secondary research questions are:
• Can effects on performance be maintained 3 months
post treatment?
• Does relearning of two relevant daily living tasks
show any generalising effect on the patients’ initiative or
need for assistance in activities of daily living?
• Costs and practicability of as well as patients’ satis-
faction with treatment.
Methods/Design
To compare the effects of errorless and trial and error
learning, we used a seven-centre single-blind, active-
controlled design with a 1:1 randomisation for two par-
allel groups. The study has been registered at the Ger-
man Trial Register (No. DRKS00003117, available at
http://apps.who.int/trialsearch). The Medical Ethics
Committee of the University Hospital Freiburg has
given ethical approval (No. 194/11).
Participants and setting
Inclusion criteria
• Persons diagnosed with Alzheimer’s disease or mixed
type dementia.
• Mini Mental State Examination: 14-24.
• Living at home.
• Carer available for rating the need for assistance in
activities of daily living.
• At least moderate need for assistance in instrumen-
tal activities of daily living; mean score of the five
household items in the performance scale of the Inter-
view for Deterioration in Daily Living Activities in
Dementia must be 2 or higher.
• Informed consent of patient and primary carer.
Exclusion criteria
• Major depression, Geriatric Depression Scale (15
items) ≥ 9.
• Major need of physical nursing care (level 2 or
higher according to the German Long-Term Care Insur-
ance Act indicated by 120 min or more per day).
• Severe behavioural disturbances, unstable medical
conditions or lack of attention and understanding of
simple task instructions in German language, which do
not allow participation in the study as judged by the
recruiting study physician.
• Involvement in other clinical trials.
• In order to achieve the recruitment of a naturalistic
sample, there will be no limitation on drug therapy.
During the trial duration, drug treatment should be kept
as constant as it is appropriate for an optimal routine
medication management. Within the statistical analysis,
we will control for possible changes in anti-dementia
drug treatment in both groups.
Setting
REDALI-DEM study centres are five outpatient memory
centres at university hospitals in Bonn, Freiburg, Mainz,
Marburg and Tübingen; one Department of a municipal
hospital in Stuttgart specialising in geronto-psychiatry;
and a centre for psychiatry in Emmendingen. The cen-
tres are located throughout Germany in urban regions
and have all provided outpatient dementia care for five
to seventeen years. Their standard service comprises
diagnostic work-up for dementia and related diagnoses
as well as recommendation of risk reduction, dementia
medication and non-pharmacological treatments. Princi-
pal investigators of the centres are psychiatrists or neu-
rologists with eight to fifteen years of experience in
dementia care. We will control for possible site effects.
Intervention
Intervention scheme
1. The scheme for the ELL and TEL intervention is
divided into two blocks (table 1). The first block consists
of 12 sessions within 10 weeks, the second block
includes 3 refresher sessions within two weeks.
2. In the first block, the general scheme is 2 sessions
per week, with following exceptional cases: When
patient is ill or not available, protocol allows
a. maximum 4 weeks without session in total
b. maximum 3 sessions per week are allowed to
catch up on the missing sessions
Table 1 Intervention scheme
Weeks 0 1-10 11 16* 19-20 26
Measurement time
points
t0 t1 t2 t3
Intervention 12
sessions
break 3 refresher
sessions
* Primary measurement time point
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3. In the second block, 3 refresher sessions must be
performed within two weeks.
4. In order to avoid contamination, ELL and TEL
interventions are delivered by separate interventionists
and the seminars on ELL and TEL interventions are
separated.
5. Each study-site has three interventionists, in order to
avoid that more than 21 interventionists are to be
instructed. At least one interventionist must be an occupa-
tional therapist. The other interventionists can be trained
from another professional background in the medical field,
e.g. psychology or nursing. Their curriculum vitae must
indicate professional experience with or special qualifica-
tion for geronto-psychiatric patients. Each site has one
main ELL interventionist, one main TEL interventionist
and one substitute interventionist, who must substitute
both, the ELL and TEL interventionist. The ELL interven-
tionist is not allowed to attend the seminar on the TEL
intervention and vice versa. The substitute interventionists
must attend both seminars, TEL and ELL. Maximal 5
treatment sessions per patient (33%) can be applied by the
substitute, in order to reduce the contamination rate.
6. In order to reduce bias by systematic selection,
interventionists of each study site are assigned by ran-
dom to be ELL or TEL interventionist.
Intervention sessions
Baseline session (same procedure in ELL and TEL
group)
1. Selection of two tasks
Together with the patient and the carer, the interven-
tionist determines two tasks to be relearned based on
following criteria:
a. Tasks are from a pre-structured pool of IADL
tasks, such as changing batteries, folding a t-shirt,
setting a table, using a coffee machine. This pool
consists of 20 IADL tasks, each of it structured in
single task steps.
b. The patient and the carer confirm that the patient
(1) was used to regularly perform the tasks within
the last year, (2) that he is not able to do so any-
more and (3) that he is still interested in. It must be
clear that the patient himself is motivated to do the
tasks again and that this motivation is not primarily
driven by the carer’s interest.
c. The interventionist asks the patient to try to per-
form the tasks without cue and can clearly observe
that the patient is not able to perform the tasks
without errors.
2. Video tapes of baseline task performance
a. Task I: The interventionist asks the patient to per-
form task I. The interventionist video records the
performance without giving any verbal cue or
instruction.
b. Task II: The same procedure.
Relearning sessions are scheduled for a total of 120
min. It is not intended to involve the carer during the
relearning sessions.
1. The ELL condition consists of the following proce-
dures.
a. The interventionist provides the patient with a
special cue card series depicting each task step.
b. He asks the patient to perform the task step by step.
c. As soon as the interventionist anticipates that the
patient could make an error, he intervenes and again
gives brief verbal instructions or short demonstration
as cues for the correct performance.
d. When the patient has performed the first step
correctly, the interventionist gives instruction for the
next step.
e. These procedures of interventionist’s instruction,
patient’s performance and interventionist’s early
intervening for avoiding errors are followed until the
whole task is performed.
f. However, the training will stop after 30 min, no
matter how many steps of the task the patient has
performed without error. When the patient shows
errorless performance of the whole task in less than
30 min training, the same task is trained again, but
not more than twice.
2. The TEL condition consists of the following proce-
dures.
a. The interventionist asks the patient to perform the
task. Cue cards are not provided.
b. When the patient makes an error, he is allowed
up to three guesses (or a maximum of 30 seconds
without guess) to correct on his own.
c. If the participant is unable to perform the step
correctly, the interventionist will use different ques-
tions relative to the purpose of the task, in order to
help the patient to find solutions.
d. If the participant is still unable to perform the
step correctly, the interventionist will give the cor-
rect verbal instruction - but no demonstration - of
what is to do next, so that the patient can perform
the step correctly.
e. These procedures of patient’s performance incl.
guessing, interventionist’s helping questions and - if
necessary - correct instructions are followed until
the whole task is performed.
f. The training will stop after 30 min, no matter how
many steps of the tasks the patient has performed.
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When the patient performed the task in less than 30
min training, the same task is trained again, but not
more than twice.
Final intervention session (same procedure in ELL and
TEL group)
Video tapes of baseline task performance
a. Task I: The interventionist again video records the
performance without giving any cue or instruction.
b. Task II: The same procedure.
Assessment sessions
The interventionist must video record the patient’s
task performance at measurement time point T2 (16
weeks after baseline) and T3 (26 weeks after baseline).
In the assessment visits, he has to follow the same pro-
cedures as in the final intervention session.
Intervention adherence
Interventionists of both treatment conditions will be
introduced during a seminar of four days, perform train-
ing sessions with two pilot patients from their study site
within the next 4 months and subsequently attend a
repetition seminar of two days. Methods of the seminar
are presentations, role-plays and feedback rounds on
role-plays of each interventionist. Experts in relearning
in AD from Nijmegen will give two separate seminars
for the ELL and TEL arm.
In both seminars interventionists will be instructed in
1. understanding the pool of the 20 IADL tasks
2. how to involve patients in selecting two relevant
tasks of daily living from the pool of IADL tasks
3. how to invite the patient to perform the task
Interventionists of the ELL group and the substitutes
will additionally learn
1. how each task is pre-structured in steps and how
to give cues for these steps
2. how to anticipate possible errors of the patient
before they occur and how to intervene and again
give cues so that the patient is motivated to
continue.
Interventionists of the TEL group and the substitutes
will additionally learn
1. how to intervene when errors occur so that the
patient is motivated to continue.
Seminars will be at different time points, in order to
prevent contamination of specific seminar content
between the ELL and TEL group. Two treatment
manuals with detailed instructions will be provided,
separately for the ELL and the TEL intervention.
Each interventionist of the ELL and the TEL condition
and each substitute interventionist must apply 12 ses-
sions to two pilot patients. The third and tenth relearn-
ing session with each pilot patient must be video
recorded. The Dutch supervisors will use these video
tapes to assess the quality of the treatment and to reflect
on possibilities for improvement within the repetition
seminar. Interventionists will receive certification based
on the quality of their pilot treatment and their contri-
bution within the repetition seminar. In order to moni-
tor the treatment adherence during the study phase, the
main ELL and TEL interventionist must provide video
tapes with two tasks of the third and tenth relearning
sessions with their first patient. The focus of the treat-
ment adherence will be the interventionists’ anticipation
of and reaction on the patient’s errors. Criteria will be
specified in the treatment manuals. In cases of inap-
propriate treatment adherence the interventionist will
receive an intensive telephone mentoring session. Conti-
nuing insufficient adherence will lead to the interven-
tionist’s replacement.
Outcome
The primary outcome is the performance of the two
selected and trained daily living tasks. The applied mea-
surement is the Task Performance Scale. It demon-
strated feasibility and responsiveness within the pilot
trial. The evaluation of task performance by measuring
the number of occurring errors or the number of insuf-
ficient task performances is an established standard in
trials on relearning cognitive or daily living tasks.
Patient’s task performance will be video recorded by the
interventionist, in order to assure blinded rating and to
avoid that the patient will have potentially confusing
contacts with several different persons. Blinded assessors
from the REDALI-DEM headquarters in Freiburg will
rate the videos regarding the number of occurring errors
and steps performed insufficiently. Table 2 shows the
primary and the secondary outcomes including mea-
surement instruments and time points. Secondary out-
come and control measures are performed by the study
physician during the patient’s visit at the study site,
except the Verbal Rating Scale for the satisfaction with
the intervention, which is applied by the interventionists
at the patient’s home.
Sample Size
A sample size of 160 subjects (l = 8.00, critical F =
3.901, numerator df = 1, denominator df = 158) is
needed for the detection of small effects size (f = 0.10)
in an analysis of variance with two groups and two
repeated measurements at baseline and week 16
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hypothesising an alpha of 5%, a power of 80% and a cor-
relation of 0.6 between the measurement points.
Reasoning
The sample size of the Nijmegen pilot study was small
(N = 12) [19]. Powerful within-subjects analyses revealed
high effect sizes in post-treatment (h2p = 0.8, p < 0.01)
and delayed assessment (h2p = 0.5, p = 0.01). In order
to avoid bias from carry-over effects between the groups
potentially occurring in a within-subjects design, in the
present trial a between-subjects design will be con-
ducted and the interaction effect between groups and
measurement points T0 (Baseline) and T2 (16 weeks
after baseline) will be analysed as primary endpoint. The
between-subjects design will reduce the statistical
power, consequently more subjects are needed. Further-
more, the correlation of r = 0.85 between the measure-
ments in control and treatment groups as stated in the
meta-analysis of Kessels et al. is quite large [18]. How-
ever, they excluded trials with between-subjects design
and only analysed studies using within-subjects design.
Considering that group differences might be influenced
by several unknown confounders in our real-life setting
at the patient’s home we assume a correlation of r = 0.6
for the power calculation. Although the meta-analysis
demonstrated large effect sizes (d = 0.87), it also found
large confidence intervals (CI95% = 0.10-1.64). It is
assumed that detecting even small effects is reasonable,
because the implementation of relearning techniques
will be a low-cost and a low-risk intervention. For these
reasons, we performed a conservative power calculation,
which is able to detect even small effect sizes for the
interaction. The patients’ planned trial flow is shown in
Figure 1.
Randomisation and Blinding
The trial statistician at a detached site will provide a 1:1
randomisation block-wise without stratification via e-
mail for each individual case after recruitment and upon
request of the site investigator. Independent assessors
are blinded to group assignment. Following the nature
of the intervention, participants are not blind for the
type of intervention. However, neither the patients nor
the interventionists will be explicitly presented an
assumption as to which intervention may be more likely
to improve activities of daily living. Moreover, both
interventions include the same amount of personal
involvement which prevents contrasting interventions
with waiting group scenarios or grossly reduced perso-
nal involvement. Blinded assessment of the treatment
effects will be achieved by videotaping the performance
of the patient and removing all hints of prior treatment
modality.
Statistical analysis
Baseline measures and demographics of participants sig-
nificantly differing at baseline in ELL and TEL group as
well as control measures are used as co-variates in an
analysis of variance. The primary intention-to-treat ana-
lysis will be compared with a per-protocol analysis.
The method “Last Observation Carried Forward” will
not be used for the imputation of missing data,
because it introduces bias in dementia research [20]. If
Table 2 Measurement scheme including primary and secondary outcome
Weeks 0 11 16* 19-20 26
Measurement time points t0 t1 t2 t3
Intervention 12 sessions break break refresher break
Primary outcome
Task Performance Scale (Rating of assessment video) x x x x
Secondary outcomes
Satisfaction with intervention (Verbal Rating Scale) each session each
session
Activities of daily living (Interview for Deterioration in Daily Living Activities
in Dementia)
x x x
Resource utilisation (Resource Utilisation in Dementia) x x x
Control measurements
Cognition (Mini Mental State Examination) x x x
Course of Dementia (Clinical Dementia Rating) x x x
Challenging behaviour (Neuropsychiatric Inventory, 12 items questionnaire) x x x
Socio-demographic data x
Depression (Geriatric Depression Scale, 15 items) x
Attention (Trail Making Test) x
Intervention adherence (rating of treatment videos) selected
sessions
* Primary measurement time point
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necessary, the Full Information Maximum Likelihood
method will be applied for data replacement [21,22].
Drop-out analysis will be performed comparing all
baseline and control measurements and follow-up data
of participants and dropouts as far as sufficient data
are available. Therefore participants are asked to give
consent to a final assessment using the Task Perfor-
mance Scale at the dropout time point. Furthermore,
the carers are asked to fill in the Interview for Dete-
rioration in Daily Living Activities in Dementia at all
measurement time points as planned.
The comparison of ELL and TEL group will be
adjusted for baseline imbalance and process variations.
Variations in treatment integrity, medication of achetyl-
cholinesterase inhibitors, and study sites will be consid-
ered as possible mediating variables and analysed with
hierarchical linear models. All statistical tests will be
two-sided on an alpha level of 0.05.
Ethical Considerations
In the trial and error condition, individuals will benefit
from the trial and error learning, but will be exposed to
the risk of experiencing deficits through insufficient task
performances more frequently than individuals in the
errorless condition. For cases where these experiences
lead to severe behavioural disturbances the trial will be
discontinued. If the ELL intervention proves to be
superior to the trial and error learning, the errorless
learning approach will reduce the experience of insuffi-
cient task performances in AD patients. In all cases, the
closest caring relative of the patient will be asked to give
assent to support the trial procedures by filling in forms
and arranging appointments. Patients who are not able
to consent will be included, if a legally appointed repre-
sentative gives consent.
Monitoring
Relevant Standardised Operating Procedures (SOP,
http://www.tmf-ev.de/Produkte/SOP.aspx) will be
adapted to the specific requirements of the REDALI-
DEM study.
SOP-pre-visit: to ensure the reliable evaluation of
recruitment capacity and competence of staff at each
site
SOP-monitor-visit: to ensure the reliable data collec-
tion and transfer and appropriate query management at
each study site
SOP-data-check: to ensure identical procedures, when
incoming data are checked for correctness and queries
are handled
SOP-data-entry-check: to ensure a rate of data entry
errors of less than 0.2%
Stages Procedures / flow chart 
Screening N  575 
Recruitment, T0-Baseline (week 0) N = 175 
Randomisation 
ELL group N = 88 
10 weeks with 12 sessions  
errorless learning 
TEL group N = 87 
10 weeks with 12 sessions  
trial and error learning 
T1-Follow-up (week 11) N = 88 T1-Follow-up (week 11) N = 87 
T2-Follow-up (week 16) N = 80 primaryendpoint T2-Follow-up (week 16) N = 80 
2 weeks with 3 refresher sessions  
errorless learning (week 19-20)  
2 weeks with 3 refresher sessions  
trial and error learning (week 19-20) 
T3-Follow-up (week 26) N = 73 T3-Follow-up (week 26) N = 72 
21 months  
study phase 
5 months  
analysis and 
implementation 
x Data cleaning, final entry control and analysis of data 
x Writing and submission of scientific papers 
x Completion of guideline and seminar concept for practitioners 
ELL=Errorless Learning; TEL=Trial and Error Learning
Figure 1 Trial flow. ELL = Errorless Learning; TEL = Trial and Error Learning.
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SOP-adverse-event: to ensure that adverse events are
disclosed early and handled appropriately
Safety
No evidence suggests that the application of learning
strategies causes medical or mental instability in AD
population. A trial steering committee will be constituted
of two persons from the applicant group and one inde-
pendent person with following responsibilities. (1) Statis-
tician: supervision of statistics and assessment adherence
monitoring. (2) Principal investigator from the Nijmegen
research group: supervision of treatment adherence mon-
itoring. (3) Professor in ethics: ethical judgement of the
study protocol and possible adverse events. Severe
adverse events are defined as non-elective hospital admis-
sions or death. Adverse events will be reported according
to the standards of Good Clinical Practice.
Discussion
It is assumed that the technique of errorless learning
may optimize procedural learning through intact impli-
cit processing in AD patients [11-19,23]. Using this
technique for relearning of ecological tasks is highly
relevant for both, patients and carers, because it might
enhance daily functioning and slow down the loss of the
patient’s autonomy. Deeper knowledge on effective
teaching techniques and beneficial instructions in AD
could have positive impact not only on health profes-
sionals but also on the interaction between patients,
informal carers and voluntary helpers, which are
increasingly deployed in dementia care.
About one third of patients with mild or moderate
dementia receive informal care of 4 to 10 h per day and
one third more than 10 h per day [24]. Our trial will
also evaluate the impact of relearning selected ADL
tasks on the informal care. We will try to collect sepa-
rate data for times of actual help and of supervision,
although we know from our former multi-centre RCT
on psychosocial interventions in AD that carer have dif-
ficulties to differentiate these two kinds of informal care.
If the stabilisation of the performance of two relevant
daily living tasks could save about 1 h of informal care
per day, the burden of care giving would be decreased
by a minimum of 10%.
The trial results will inform us to improve the first exist-
ing evidence-based practice guideline for instructing indi-
viduals with neurogenic memory impairments [25]. An
improved, user-friendly, and more detailed practice guide-
line will allow an efficient implementation of the implicit
learning program for a wide range of care and service pro-
viders in dementia, such as physicians, occupational, phy-
sical and speech therapists, neuropsychologists, nurses,
social workers, family carers and volunteers in health care.
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